Analysis of cytokine pattern in exhaled breath condensate of patients with squamous cell lung carcinoma

International Journal of Biological Markers

Volumn 25, Issue 1, 2010, Pages 52-56

  Barta, Imre ^a   Kullmann, Tamas ^a   Csiszer, Eszter ^a   Antus, Balazs ^a  

^a NATIONAL KORANYI INSTITUTE OF PULMONOLOGY   (Hungary)

Author keywords

Biomarker; Cancer; Cytokine; Exhaled breath condensate; Lung

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYTOKINE;

ADULT; ARTICLE; BREATH ANALYSIS; CANCER PATIENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EXPIRED AIR; FEMALE; HUMAN; LUNG FUNCTION; LUNG SQUAMOUS CELL CARCINOMA; MALE; MICROARRAY ANALYSIS; PILOT STUDY; RESPIRATORY TRACT INFLAMMATION; SMOKING;

EID: 77951007583     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460081002500108     Document Type: Article

References (24)

1. Bach PB, Silvestri GA, Hanger M, Jett JR. Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132: S69-S77.
2. Kharitonov SA, Barnes PJ. Exhaled biomarkers. Chest 2006; 130: 1541-1546
3. Horvath I, Hunt J, Barnes PJ, et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005; 26: 523-548
4. Hultschig C, Kreutzberger J, Seitz H, et al. Recent advances of protein microarrays. Curr Opin Chem Biol 2006; 10: 4-10.
5. Zhong L, Coe SP, Stromberg AJ, et al. Profiling tumor-associated antibodies for early detection of non-small cell lung cancer. J Thorac Oncol 2006; 1: 513-519
6. Conrad DH, Goyette J, Thomas PS. Proteomics as a method for early detection of cancer: a review of proteomics, exhaled breath condensate, and lung cancer screening. J Gen Intern Med 2008; 23: S78-S84.
7. Kullmann T, Barta I, Csiszer E, et al. Differential cytokine pattern in the exhaled breath of patients with lung cancer. Pathol Oncol Res 2008; 14: 481-483
8. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD Executive Summary. Am J Respir Crit Care Med 2007; 176: 532-555
9. Rami-Porta R, Crowley JJ, Goldstraw P. The revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg 2009; 15: 4-9.
10. Czebe K, Kullmann T, Csiszer E, et al. Variability of exhaled breath condensate pH in lung transplant recipients. Respiration 2008; 75: 322-327
11. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171: 912-930
12. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152: 1107-1136
13. Westhoff M, Litterst P, Freitag L, Urfer W, Bader S, Baumbach JI. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Thorax 2009; 64: 744-748
14. Phillips M, Gleeson K, Hughes JM, et al. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet 1999; 353: 1930-1933
15. Phillips M, Cataneo RN, Cummin AR, et al. Detection of lung cancer with volatile markers in the breath. Chest 2003;123: 2115-2123 (Pubitemid 36706741)
16. Gordon SM, Szidon JP, Krotoszynski BK, et al. Volatile organic compounds in exhaled air from patients with lung cancer. Clin Chem 1985; 31: 1278-1282
17. Machado RF, Laskowski D, Deffenderfer O, et al. Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med 2005; 171: 1286-1291
18. Chan HP, Lewis C, Thomas PS. Exhaled breath analysis: novel approach for early detection of lung cancer. Lung Cancer 2009; 63: 164-168
19. Carpagnano GE, Foschino-Barbaro MP, Resta O, et al. Endothelin-1 is increased in the breath condensate of patients with non-small-cell lung cancer. Oncology 2004; 66: 180-184
20. Carpagnano GE, Resta O, Foschino-Barbaro MP, et al. Interleukin-6 is increased in breath condensate of patients with non-small cell lung cancer. Int J Biol Markers 2002; 17: 141-145 (Pubitemid 34873801)
21. Dalaveris E, Kerenidi T, Katsabeki-Katsafli A, et al. VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer. Lung Cancer 2009; 64: 219-225
22. Carpagnano GE, Spanevello A, Curci C, et al. IL-2, TNF-alpha, and leptin: local versus systemic concentrations in NSCLC patients. Oncol Res 2007; 16: 375-381
23. Malerba M, Ragnoli B, Corradi M. Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects. Monaldi Arch Chest Dis 2008; 69: 128-133
24. Bessa V, Tseliou E, Bakakos P, Loukides S. Noninvasive evaluation of airway inflammation in asthmatic patients who smoke: implications for application in clinical practice. Ann Allergy Asthma Immunol 2008; 101: 226-232